NCT04636411View on ClinicalTrials.gov

Effects of Oral Magnesium Supplementation on Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions
Type2 Diabetes
Interventions
DIETARY_SUPPLEMENT

Oral Magnesium Supplementation

250 mg of elemental magnesium daily for three months

OTHER

Standard Care for diabetic patients

Health education, oral antihyperglycemic medications according to American Diabetes Association (ADA) guidelines

Trial Locations (1)

11562

Mokattam primary health care unit, Cairo

All Listed Sponsors
collaborator

Walaa Reda Abdel Fattah Mohamed Badr

UNKNOWN

collaborator

Marwa Mostafa Ahmed

UNKNOWN

collaborator

Moushira Hosny Ezzelarab Sayed

UNKNOWN

collaborator

Nagwa Eid Sobhy Saad

UNKNOWN

lead

Samar Fares, MD

OTHER

NCT04636411 - Effects of Oral Magnesium Supplementation on Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter